Insurance Agent Registry Build vs Buy | Moring
For insurance agent registries, the build-versus-buy question turns on whether the registry must operate as a live enforcement dependency or can remain a catalog. Buying gets discovery, policy mapping, and evidence workflows immediately; building offers control over integration with carrier systems and delegated-authority structures. Most insurers should buy the registry and build only the integrations that make it authoritative.
Short answer
For insurance agent registries, the build-versus-buy question turns on whether the registry must operate as a live enforcement dependency or can remain a catalog. Buying gets discovery, policy mapping, and evidence workflows immediately; building offers control over integration with carrier systems and delegated-authority structures. Most insurers should buy the registry and build only the integrations that make it authoritative.
How it works
The registry decision starts with its role. Trussed argues the registry is a governance primitive, not a compliance document: it only delivers value when runtime enforcement, audit tooling, and incident response query the same authoritative record. That bar is high for a homegrown tool. A build must replicate inventory, ownership, permission scopes, version linkage, and evidence indexing before it can serve enforcement, while a purchased registry starts from that baseline.
Vendors in this category illustrate the range. TrueFoundry positions its registry as a centralized catalog for discovery, governance, and reuse across multi-agent systems, handling high request rates on modest infrastructure. Credo AI positions its Agents Registry around compliance automation, surfacing risk, and staying audit-ready, asking whether enterprises can trace what decisions agents make and which tools and data they accessed. Kong frames agentic governance broadly as managing the authority handed to autonomous systems.
Insurers have specific integration requirements that should drive the comparison. The registry must connect to the identity fabric that a United States standards concept paper proposes for agents, including OAuth, OpenID Connect, and SCIM treatment of agents as identifiable entities. It must reflect delegated-authority structures that Trussed's MGA guidance highlights, where carrier requirements and consumer impact shape control expectations. And it must produce evidence aligned to DORA and the EU AI Act without manual assembly.
The build case is real but narrow: an insurer with an unusually strong platform team and nonstandard carrier systems may need custom connectors, and hybrid patterns are common. Domo and OutSystems both observe that most enterprises run hybrid approaches across their agent tooling. The reasonable pattern is to buy the registry core, which is a commodity of inventory and policy mapping, and build the connectors that bind it to policy administration, claims, and underwriting systems.
Decagon's observation supports buying the core: Microsoft's inventory recommendation becomes the registry in practice, and it is usually the first thing worth building, meaning the first thing to have standing, not necessarily the first thing to hand-code. Insurers that hand-code inventory often stall at the enforcement boundary, where policy evaluation, approval workflows, and evidence chains demand sustained engineering.
The decision framework for an insurance technology leader is therefore: does the option query as a live system from enforcement points, map owners and risk tiers per the NAIC AI Model Bulletin's expectations, produce EU AI Act and DORA-aligned evidence, and integrate with carrier identity and delegated authority. Buy where those are table stakes; build only the edges that are genuinely yours.
Frequently asked questions
Should an insurance carrier build or buy an AI agent registry?
Buy the registry core and build only the integrations that bind it to carrier systems. Trussed argues the registry must operate as a live system that enforcement, audit, and incident response query, which is a high bar for hand-built tooling. Vendors such as TrueFoundry and Credo AI deliver inventory, policy mapping, and audit evidence as a baseline, while the insurer's genuinely custom work is connecting the registry to policy administration, claims, and delegated-authority structures.
What capabilities distinguish a production-grade agent registry?
Look for a registry with live queryability from enforcement points, ownership and risk-tier records, version and approval linkage, and evidence chains that support DORA and EU AI Act obligations. Credo AI frames the test as traceability: can you see what decisions agents made and which tools and data they accessed. TrueFoundry emphasizes catalog scale and discovery. For insurers, add integration with identity protocols such as OAuth and SCIM, as a United States standards concept paper proposes for agents.
When does building a registry in-house make sense for an insurer?
Mostly when carrier systems are nonstandard enough that vendor connectors cannot bind the registry to the systems that matter, and when a platform team can sustain enforcement-grade engineering. Even then, the hybrid pattern Domo and OutSystems describe across enterprise tooling suggests buying the inventory and policy core. Decagon's observation that the registry is usually the first thing worth having standing supports acquiring the baseline quickly rather than hand-coding it.
How does the registry choice affect MGA and delegated-authority compliance?
Trussed's MGA guidance requires each AI action to be attributable, policy-aware, and reviewable in relation to delegated authority, carrier requirements, and consumer impact. A purchased registry configured with those relationships produces that evidence as a byproduct; a partial build often cannot, leaving the MGA to assemble records manually at exam time. Since DORA and the EU AI Act both demand reliable evidence for critical and high-risk functions, the registry choice directly shapes audit outcomes.